Page Title
Pressemeldung

Erster Studienteilnehmer eingeschlossen

Vakzine Projekt Management GmbH: First volunteer enrolled in Phase II/III Study of SIIPL Tdap vaccine in Comparison with Boostrix® in Healthy Participants. More!

Scroll to Top